Xebio Holdings Co., Ltd.
Xebio HD Fiscal Year Ending March 2026 Earnings｜Sales ¥253.2 billion (YoY +0.7%)
Xebio Holdings announced its fiscal year ending March 2026 results, with sales of ¥253.2 billion (YoY +0.7%) and a net loss of △2,423 million yen. The company is working on business restructuring and profitability improvement while responding to changes in domestic and international market environments.
Key Figures
- Net Sales: ¥253.2 billion (YoY +0.7%)
- Net Profit: △2,423 million yen (Significant decrease YoY)
- Operating Income: ¥2,370 million (YoY +66.4%)
AI要約
Performance Overview
Xebio Holdings announced its fiscal year ending March 2026 results, with sales reaching ¥253.2 billion (YoY +0.7%). Net profit significantly declined to △2,423 million yen, while operating income increased by 66.4% to ¥2,370 million, indicating an improvement in profitability. The company is restructuring its business and responding to intensifying domestic and international competition and market changes.
Future Outlook and Strategy
Going forward, the company aims to strengthen its domestic retail operations and expand overseas, focusing on stabilizing its earnings base. Particular efforts will be directed toward business restructuring and cost reduction to enhance profitability, alongside advancing new business ventures and digitalization to strengthen competitiveness. The company is also working on optimizing its business portfolio and creating new revenue sources for long-term growth.
Net Sales Trend
Net Profit Trend
Operating Income
Xebio Holdings Inc.
Company overview · Stock price · Financial data · All IR
